George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
The mysterious multi hundred thousand buy trades continue while forty 66p bot trades drags the price down!
2 million buy! Is it for the dividend or something more?
Dividend set for May/June on shareholder approval. Anyone going to object? Maybe then get further news on another special. I can’t seen the directors having emotions for takeovers, more ambitious to get the company sold and retire hopefully. Great job though
Some thumping trades this morning. Two well over a million and two at half a million. I was wondering about the surplus cash. Ip dividend is not overly generous. Singer say there remains the opportunity for second special dividend on top of the maiden dividend. Be nice if they could manage both and the takeover!
What the results do show is the impressive impact the senior management team have had in the last 3+ years to get the business to this strong and growing position. It does look like there may be a changing of the guard - Michael Roller is going part time; and you wonder if Ian Johnson is considering how long he will remain with the business (he is 70). AstraZeneca remain a major shareholder - and active investor Richard Griffiths still retains a 24% holding. SB
SB. Indeed the hidden asset of 600 million tax credit as Chris Mills put it. Plus 22.5 million cash as of end of february. Valuation doesnt look stretched to me for 18 % growth compounding. The market is also growing possibly to 400 million in next decade. The improvement and cost of drugs also necessitates the accuracy of Feno for which Niox are currently in a field of their own.
*oogle.....
Morning ooggle - decent position when you compare the company to where it was a few years ago. At a market cap of c.£270m this looks fully valued for me at present based on operating profit (£4.6m). What is starting to make a major impact is the tax credit - which contributed more profit (£5.4m) than actual trading operations - and there's a lot more to come from that source - and that's an area where potential suitors may look to take advantage of. SB
Confirmed 23 year results from January. 18 percent revenue growth. 1p dividend confirmed for 2023 but no date set yet. Nearly 20 million cash balance plus whatever assets year (possibly another 5 million) . Lungfit approval in USA to add 10 million dollars over 3 years. Strong point made about the importance of the uptake of FeNo testing with better and more expensive drugs becoming available. Asset value just over 80 million. All in all the stock set to become very undervalued if progress only continues at this pace but of course likely to accelerate further with development of home kit and the larger updated version of current diagnostic machine. Still early days for a bid maybe, but depends how much quicker a larger company could place and develop their products. I would imagine the current sp would be largely supported by todays update, but who can tell in this mad market!
Apologies replying to Silverblade. Also should have said only 800,000 ISA accounts fully invested. Good to have some company. Getting a bit worried everyone had sneaked off! I suppose we are a bit egg in one basket but it’s the hell of an egg
Corry . Certainly not complaining about an extra ISA. It’s just the idea that it will help investment in British stocks is not very convincing or well thought through for a man of Hunt’s calibre and chaperones. How many investors who don’t already own British stock are likely to invest in them because of this extra allowance. There are only about 800,000 ISAinvestment accounts currently anyway
Hopefully the UK market will have got out the doldrums long before then on it's own, or half of it already sold off to PE at undervalue before the £5k even has a chance.
Might be in place by end of next tax year. From the Treasury consultation doc:
"4.1 Following consultation, the government will confirm the final scheme design before bringing forward any necessary legislation. It will also set out more detail on the timeframe for implementation and the necessary reporting tools."
Consultation is running from 6 March to 6 June 24.
On the other hand.....isa allowance is now £25k a year.....so its not all grim oogle! SB
thank you very much for the extra 5k british isa. already invested in uk stocks with global businesses. fail to see the significance of this move. if he made all isa’s british investment only that would clearly achieve what he wanted. yet more half ****ed ideas from the chancellor
Singer note ‘Core holding in the sector’. Well that livened it up a bit or something stirring in the wood shed after months of drifting. Approaching the prelims in a couple of weeks.
This is as very strange market. Such low volumes in fairly wide trading ranges on little news. Good to see this stock as solid as has been. I guess the perpetual expectation of a takeout keeps the interest sharpened, but actually the fundamentals remain pretty solid too. Results in March should clarify this and news of dividend could make quite a difference. I have continued to be a buyer as a find it really hard to find another stock quite as attractive in terms of stability and compounding value. In a way I would be happy to see the continued growth bear fruit rather than a takeout. the risk of having to start all over again looking for something of comparative value is not so pappealing
For those who follow such things, NIOX appears to have made a rather good ‘Key reversal’ today which may well presage a significant upward movement.
The NIOX share price has behaved well in the past when patterns have formed/completed.
Watch this space…….
Quite similar to last years trading after the capital reduction announcement when it just drifted around until the actual results were published. I think Mills put it in a nutshell. ‘The market sees it as expensive but the cash generation is rapidly catching up with the valuation and completely excludes the the 600 million tax loss carried over from circasia days which means it will never have to pay tax for the foreseeable.
These fell back to 58p 22/1/24.
Sold that part buy back of 57.4p for a higher 64p on 13th July 2023.
Buy 22nd August 2023 they were 72p Just as well a part execution on the buy.
Hardman & Co
NIOX Group (NIOX) NIOX has evolved from the old Circassia group, which was a disastrous investment. Today, NIOX is focused on improving asthma diagnosis through its fractional exhaled nitric oxide (FeNO) test, which is a by-product of inflammation found in the air that you breathe out. Sales are made through distributors and are strong in countries where air pollution is a problem, such as the US and China. The business is profitable, growing, and cash-generative. In 2023, NIOX paid its first dividend (2.5p special dividend) and expects to pay a final dividend for fiscal 2023, due to be announced in March 2024. Consequently, the shares have seen a good recovery in 2023, rising 84%.
Typical reaction from a nervous market. There have been some similar reaction to strong results from other Aim companies this month. 18.8 revenue almost doubled to £36 million full year. Cash was up about £4 million after specially div of over £10 million. This was a strong in line performance. Should be more news about the permanent introduction of a dividend in March statement. Appointment of joint broker/financial advisor is interesting . Does that mean they don’t have much confidence in Singer? I’m sure there was mention of a partnership last year. Again will need to see March statement on that too. Griffith trimmed his holding from 29 percent to 23 percent, which is understandable. Stanley came aboard for 5 percent when the shares were high 60p’s. All looks pretty fine to me. Mills said if we get lucky should get bought out. I wondered if financial advisor has been installed for that eventuality. The world is not in a good place right now so the much talked about bull return looks to be on hold. Gl
Trading update is fantastic, but I think the other RNS, the one about appointing a joint broker, has spooked small investors due to placing concerns, and that's why the price has dropped.
Buy Order Details
1,658
NIOX
NIOX Group
Price Traded
£0.602874
Total Cost
£999.57
this is showing as a sell on Advfn
Ah, looks like there was a panic seller on the bell who was either out to do what he achieved or didn’t know how to trade AIM in size.
Extraordinary reaction to trading statement - SP marked down by 7%! Incredible, what do management have to do to satisfy this crap AIM market rigged by brokers for their own purposes?